Literature DB >> 22740580

Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective.

Giuseppe Lippi, Mario Plebani.   

Abstract

Entities:  

Year:  2012        PMID: 22740580     DOI: 10.1515/cclm-2012-0344

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  3 in total

1.  Neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting.

Authors:  Sinan Demirtas; Ahmet Caliskan; Oguz Karahan; Celal Yavuz; Orkut Guclu; Mustafa Cagdas Cayir; Faruk Toktas; Osman Tiryakioglu
Journal:  Exp Clin Cardiol       Date:  2013

Review 2.  Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma.

Authors:  Kai Che; Wenkai Han; Mingxin Zhang; Haitao Niu
Journal:  Oncol Lett       Date:  2020-12-24       Impact factor: 2.967

3.  Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?

Authors:  Naomi Pode Shakked; Maria Helena Santos de Oliveira; Isaac Cheruiyot; Justin L Benoit; Mario Plebani; Giuseppe Lippi; Stefanie W Benoit; Brandon Michael Henry
Journal:  Clin Biochem       Date:  2022-01-31       Impact factor: 3.625

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.